Chlorin e6‐Loaded Nanostructured Lipid Carriers Targeted by Angiopep‐2: Advancing Photodynamic Therapy in Glioblastoma
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202402823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Carlotta Pucci und 9 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Italiano di Tecnologia, Smart Bio-Interfaces, Viale Rinaldo Piaggio 34, Pontedera, 56025, Italy. Hauptthemen laut MEDLINE: Photochemotherapy, Glioblastoma, Porphyrins, Lipids. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Glioblastoma (GBM) is a highly aggressive brain tumor known for its resistance to standard treatments. Despite surgery being a primary option, it often leads to incomplete removal and high recurrence rates. Photodynamic therapy (PDT) holds promise as an adjunctive treatment, but safety concerns and the need for high‐power lasers have limited its widespread use. This research addresses these challenges by introducing a novel PDT approach, using chlorin e6 (Ce6) enclosed in nanostructured lipid carriers (Ang‐Ce6‐NLCs) and targeted to GBM with the angiopep‐2 peptide. Remarkably, a single 5‐min irradiation session with LEDs at 660 nm and low power density (10 mW cm − 2 ) proves effective against GBM, while reducing safety risks associated with high‐power lasers. Encapsulation improves Ce6 stability and performance in physiological environments, while angiopep‐2 targeting enhances delivery to GBM cells, maximizing treatment efficacy and minimizing off‐target effects. The findings demonstrate that Ang‐Ce6‐NLCs‐mediated PDT brings about a significant reduction in GBM cell viability, increases oxidative stress, reduces tumor migration, and enhances apoptosis. Overall, such treatment holds potential as a safe and efficient intraoperative removal of GBM infiltrating cells that cannot be reached by surgery, using low‐power LED light to minimize harm to surrounding healthy tissue while maximizing tumor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istituto Italiano di Tecnologia, Smart Bio-Interfaces, Viale Rinaldo Piaggio 34, Pontedera, 56025, Italy.
- Scuola Superiore Sant'Anna, The BioRobotics Institute, Viale Rinaldo Piaggio 34, Pontedera, 56025, Italy.
- Politecnico di Torino, DIMEAS, Corso Duca degli Abruzzi 24, Torino, 10129, Italy.
- IRCCS Istituto Giannina Gaslini, Core Facilities-Clinical Proteomics and Metabolomics, Via Gerolamo Gaslini 5, Genova, 16147, Italy.
ORCID-Profile: Carlotta Pucci
Förderung
- AIRC
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Pucci, C., De Pasquale, D., Degl'Innocenti, A., Montorsi, M., Desii, A., Pero, M., Martinelli, C., Bartolucci, M., Petretto, A., & Ciofani, G. (2025). Chlorin e6‐Loaded Nanostructured Lipid Carriers Targeted by Angiopep‐2: Advancing Photodynamic Therapy in Glioblastoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402823
Vancouver
Pucci C, De Pasquale D, Degl'Innocenti A, Montorsi M, Desii A, Pero M, et al. Chlorin e6‐Loaded Nanostructured Lipid Carriers Targeted by Angiopep‐2: Advancing Photodynamic Therapy in Glioblastoma. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402823
BibTeX
@article{Pucci2025,
author = {Pucci, Carlotta and De Pasquale, Daniele and Degl'Innocenti, Andrea and Montorsi, Margherita and Desii, Andrea and Pero, Marta and Martinelli, Chiara and Bartolucci, Martina and Petretto, Andrea and Ciofani, Gianni},
title = {Chlorin e6‐Loaded Nanostructured Lipid Carriers Targeted by Angiopep‐2: Advancing Photodynamic Therapy in Glioblastoma},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202402823}
}
EUVIMED